4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-22-031705
Options or other derivatives
- Chief Medical Officer acquired 117,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…